Dr.Cong Xu is vice President of Lilly Asia Foundation. Prior to that, he was responsible for the formulation and execution of China r&d strategy for oncology products in development, medical affairs for marketed products, and co-development of external joint projects at Eli Lilly. Dr. Xu cong holds a PhD in biological science from Clemson University in the United States, an MBA degree from UBC University in Canada and a clinical undergraduate degree from Tongji Medical College of Huazhong University of Science and Technology. He is also a licensed physician in the United States.
- Next：Tracy Song